Hematological Outcomes From A Phase 3, Placebo-Controlled, Randomized Clinical Trial Of Pi3K Delta Inhibitor Leniolisib In Patients With Activated Pi3K Delta Syndrome (Apds/Pasli)
Leniolisib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Hematological Outcomes From A Phase 3, Placebo-Controlled, Randomized Clinical Trial Of Pi3K Delta Inhibitor Leniolisib In Patients With Activated Pi3K Delta Syndrome (Apds/Pasli) ### Output: Leniolisib